Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A Phase I, open-label, multi-center study of radiation dosimetry, safety, and tolerability of extended lutetium (177Lu) vipivotide tetraxeta… Recruiting

2024-512338-13-00 Metastatic Castration-Resistant Prostate Cancer 2024-11-11
MYELOFLUDATEP: Exploratory study evaluating the value of 18F-Fludarabine PET for the initial or relapsed assessment and therapeutic evaluati… Recruiting

2024-515219-23-00 multiple myeloma 2024-11-08
18F-DPA714 PET-MRI study to improve preoperative localisation of the epileptic focus to be resected in drug-resistant partial epilepsy. Recruiting

2024-517638-16-00 Patients with drug-resistant epilepsy who are candidate 2024-11-04
A Study to Investigate the Safety and Tolerability of Ziftomenib Combinations in Patients with Relapsed/Refractory Acute Myeloid Leukemia Recruiting

2023-510288-37-00 Relapsed and/or refractory Acute Myeloid Leukemia 2024-11-01
MCA-derived MSC therapy in renal transplant recipients Recruiting

2024-512553-25-00 Rejection transplanted kidney 2024-10-15
CLADRIBINE DOSE ESCALATION IN CONDITIONING REGIMEN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (Allo-HSCT) FOR REFRACTORY AC… Recruiting

2024-515737-14-00 Acute leukemia and myelodysplastic syndromes 2024-10-07
A study in people with obesity to test the effects of different doses of BI 456906 compared with semaglutide on glucagon receptor activity i… Recruiting

2024-515417-17-00 No targeted indication. Male and female subjects with o 2024-10-01
The Neurobiological Effect of 5-HT2AR Modulation Recruiting

2024-515961-33-00 No medical conditions or diseases will be examined, onl 2024-09-02
Phase Ib Open Label Basket Trial of RAY121 to Inhibit Classical Complement Pathway in Immunological Diseases (RAINBOW Trial) Recruiting

2023-507692-21-00 Bullous pemphigoid 2024-08-22
STRATIFY; Near-infrared fluorescence molecular imaging of adalimumab-800CW to elucidate the drug distribution throughout inflamed tissue in … Recruiting

2024-513390-50-00 Crohn's disease 2024-08-06
Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype Recruiting

2023-509183-17-00 Colorectal cancer, liver metastases 2024-08-01
Treatment of cancer with Immune Checkpoint Inhibition therapy boosted by High Intensity Focused Ultrasound Histotripsy (the iFOCUS study) Recruiting

2023-509210-10-00 Metastatic or unresectable solid malignancies. Standard 2024-07-26
Study of RMC-6291 and RMC-6236 With Other Anti-Cancer Agents in Patients With RAS G12C-Mutated NSCLC - Subprotocol A Recruiting

2023-509571-16-00 Lung Cancer 2024-07-17
A study of RMC-6236 in combination with pembrolizumab in participants with nonsmall cell lung cancer with certain mutations -Subprotocol B Recruiting

2023-509572-42-00 Lung Cancer 2024-07-17
A clinical trial to learn how an investigational drug (MP-101) affects on the laboratory signs of the disease when given to Amyotrophic Late… Recruiting

2023-507195-43-00 Amyotrophic Lateral Sclerosis (ALS) 2024-07-01
A Single-Arm, Open-Label, Phase 1 Study to Determine the Safety, Tolerability and Preliminary Efficacy of Obecabtagene Autoleucel in Patient… Recruiting

2023-508236-60-00 Severe, Refractory Systemic Lupus Erythematosus 2024-06-13
A Single-Arm, Open-Label, Multicenter, Phase 1b/2 Study Evaluating the Safety and Efficacy of AUTO1 (obecabtagene autoleucel [obe-cel]) in P… Recruiting

2023-506307-26-00 B-cell Acute Lymphoblastic Leukemia (B ALL) and Aggress 2024-05-22
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3938577 in Healthy Participants and Participants wit… Recruiting

2023-510365-10-00 Type 1 Diabetes Mellitus 2024-04-29
A phase 1 study of FluBHPVE6E7 immunotherapy in patients with HPV16-associated oropharyngeal squamous cell carcinoma Recruiting

2024-514413-36-00 Treatment of human papilloma virus (HPV) associated inf 2024-04-29
Nebulized fentanyl in healthy volunteers: comparison of facial versus intranasal aerosol administration by pharmacometric modeling. Pilot st… Recruiting

2023-506016-40-00 Healthy Volunteers 2024-04-19
Individualization of dosage regimens in obese patients: application to acyclovir Recruiting

2022-500879-31-00 obesity 2024-04-09
A study to compare the amount of milvexian in blood when given as pediatric and adult tablet formulations, to assess the effect of food inta… Recruiting

2023-508515-23-00 atherothrombotic and thromboembolic disorders 2024-03-19
A study to test how BI 764532 is taken up by tumours in people with small-cell lung cancer or neuroendocrine cancer Recruiting

2022-501818-54-00 Small cell lung carcinoma (SCLC) 2024-02-22
Safety, tolerability, and biodistribution of [89Zr]Zr-DFO-APAC (Phase 0) in subjects with peripheral arterial occlusive disease / critical l… Recruiting

2023-505287-11-01 Critical limb ischemia 2024-02-01